|
|||||
|
|
Cost‐effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib |
|
| Authors: | Pengfei Zhang Yu Yang Feng Wen John Wheeler Ping Fu Qiu Li |
| Affiliation: | 1. Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China;2. West China Biostatistics and Cost‐Benefit Analysis Center, Sichuan University, Chengdu, Sichuan, China;3. School of Public Health, University of Michigan, Ann Arbor, Michigan, USA;4. Division of Nephrology, Department of Internal Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China |
| Abstract: | |
| Keywords: | cost‐effectiveness antiviral therapy hepatitis B virus hepatocellular carcinoma sorafenib |